Skip to main content

Cellectar Biosciences, Inc.

CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001279704

No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Cellectar Biosciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
−1 vs. Q2 2024
Shares held
14.0M
+2.64M (+23.2%) vs. Q2 2024
Total value
$30.0M
+$2.29M (+8.3%) vs. Q2 2024
New holders
6
8 more added
Sold out
7
10 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 35 institutions
Q1 2021: 45 institutionsQ2 2021: 46 institutionsQ3 2021: 40 institutionsQ4 2021: 42 institutionsQ1 2022: 32 institutionsQ2 2022: 33 institutionsQ3 2022: 22 institutionsQ4 2022: 26 institutionsQ1 2023: 21 institutionsQ2 2023: 21 institutionsQ3 2023: 20 institutionsQ4 2023: 26 institutionsQ1 2024: 45 institutionsQ2 2024: 37 institutionsQ3 2024: 35 institutionsQ4 2024: 30 institutionsQ1 2025: 32 institutionsQ2 2025: 19 institutionsQ3 2025: 21 institutionsQ4 2025: 20 institutionsQ1 2026: 19 institutionsQ2 2026: 29 institutions
Value heldQ3 2024: $30.0M
Q1 2021: $24.2MQ2 2021: $14.9MQ3 2021: $6.77MQ4 2021: $4.38MQ1 2022: $4.69MQ2 2022: $3.61MQ3 2022: $2.14MQ4 2022: $3.22MQ1 2023: $2.43MQ2 2023: $3.08MQ3 2023: $3.85MQ4 2023: $23.9MQ1 2024: $36.3MQ2 2024: $28.3MQ3 2024: $30.0MQ4 2024: $1.52MQ1 2025: $1.63MQ2 2025: $734.0KQ3 2025: $1.65MQ4 2025: $1.04MQ1 2026: $812.9KQ2 2026: $9.08M
Institutions holding CLRB and their total value by quarter
QuarterHoldersValue
Q2 202629$9.08M
Q1 202619$812.9K
Q4 202520$1.04M
Q3 202521$1.65M
Q2 202519$734.0K
Q1 202532$1.63M
Q4 202430$1.52M
Q3 202435$30.0M
Q2 202437$28.3M
Q1 202445$36.3M
Q4 202326$23.9M
Q3 202320$3.85M
Q2 202321$3.08M
Q1 202321$2.43M
Q4 202226$3.22M
Q3 202222$2.14M
Q2 202233$3.61M
Q1 202232$4.69M
Q4 202142$4.38M
Q3 202140$6.77M
Q2 202146$14.9M
Q1 202145$24.2M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q2 2024.

Institutions holding CLRB in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Rosalind Advisors, Inc.3,671,550$7.86M5.21%+965,934+35.7%Added
AIGH Capital Management LLC3,197,394$6.84M3.20%+161,207+5.3%Added
Nantahala Capital Management, LLC2,712,443$5.80M0.49%+879,118+48.0%Added
Vanguard Group Inc1,726,986$3.70M0.00%+163,000+10.4%Added
ADAR1 Capital Management, LLC1,022,161$2.19M0.37%+340,067+49.9%Added
Geode Capital Management, LLC352,452$754.4K0.00%+11,266+3.3%Added
BlackRock, Inc.232,320$497.2K0.00%+232,320New
Altium Capital Management LP215,000$460.1K0.14%+215,000New
Bank of America Corp165,079$353.3K0.00%+102,005+161.7%Added
Morgan Stanley139,231$298.0K0.00%+55,789+66.9%Added
Barclays PLC120,497$257.9K0.00%−51,700−30.0%Reduced
State Street Corp116,814$250.0K0.00%00.0%Unchanged
Northern Trust Corp61,094$130.7K0.00%00.0%Unchanged
XTX Topco Ltd53,022$113.5K0.01%−10,282−16.2%Reduced
Raymond James Financial Services Advisors, Inc.30,000$64.2K0.00%00.0%Unchanged
Pale Fire Capital SE25,030$53.6K0.01%+25,030New
Sequoia Financial Advisors, LLC23,800$50.9K0.00%+23,800New
JPMorgan Chase & Co23,169$49.6K0.00%−27,946−54.7%Reduced
Two Sigma Securities, LLC22,799$48.8K0.00%+22,799New
Goldman Sachs Group Inc20,525$43.9K0.00%−14,475−41.4%Reduced
Integrated Wealth Concepts LLC20,000$42.8K0.00%00.0%Unchanged
Susquehanna International Group, LLP16,134$34.5K0.00%−29,617−64.7%Reduced
Commerce Bank14,000$30.0K0.00%00.0%Unchanged
Oppenheimer & Co Inc12,500$26.8K0.00%+12,500New
Advisor Group Holdings, Inc.2,846$6.09K0.00%00.0%Unchanged
UBS Group AG2,577$5.51K0.00%−12,223−82.6%Reduced
Tower Research Capital LLC (TRC)2,285$4.89K0.00%−29,540−92.8%Reduced
Group One Trading, L.P.1,398$2.99K0.00%−3,556−71.8%Reduced
BFSG, LLC1,000$2.14K0.00%00.0%Unchanged
US Bancorp385$8240.00%00.0%Unchanged
Citadel Advisors LLC303$6480.00%−49,924−99.4%Reduced
EnRich Financial Partners LLC102$2180.00%00.0%Unchanged
Harbour Investments, Inc.40$860.00%00.0%Unchanged
AllSquare Wealth Management LLC18$390.00%00.0%Unchanged
Simplex Trading, LLC425$00.00%−7,767−94.8%Reduced
Hudson Bay Capital Management LP0$00.00%−150,000−100.0%Sold out
Acuta Capital Partners, LLC0$00.00%−70,500−100.0%Sold out
Millennium Management LLC0$00.00%−42,647−100.0%Sold out
Jane Street Group, LLC0$00.00%−41,865−100.0%Sold out
Verition Fund Management LLC0$00.00%−15,217−100.0%Sold out
Coastal Bridge Advisors, LLC0$00.00%−11,000−100.0%Sold out
Redwood Wealth Management Group, LLC0$00.00%−1,000−100.0%Sold out
BlackRock Inc.––––Not filed